<table
    cellpadding="0"
    cellspacing="0"
    width="100%"
    role="presentation"
    style="min-width: 100%"
    class="stylingblock-content-wrapper"
>
    <tr>
        <td style="padding-bottom: 10px" class="stylingblock-content-wrapper camarker-inner">
            <div style="text-align: left">
                <span
                    style="
                        font-family: arial, helvetica, sans-serif;
                        font-size: 16px;
                        line-height: 22px;
                        color: #333;
                    "
                    ><span style="font-weight: bold"
                        >Leading Edge Treatment for PSMA Positive Prostate Cancer</span
                    ></span
                ><br />
                <br />
                <span
                    style="
                        font-family: arial, helvetica, sans-serif;
                        font-size: 16px;
                        line-height: 22px;
                        color: #333;
                    "
                    >CTCA Chicago is a site of care for PluvictoÂ®, a radiopharmaceutical approved
                    by the FDA as the first targeted radioligand therapy for treatment of
                    progressive, PSMA positive metastatic prostate cancer. CTCA Chicago also offers
                    leading edge imaging to identify PSMA positive lesions.
                </span>
            </div>
        </td>
    </tr>
</table>
